[go: up one dir, main page]

WO2017101583A1 - Method for preparing membrane-covered intravascular stent - Google Patents

Method for preparing membrane-covered intravascular stent Download PDF

Info

Publication number
WO2017101583A1
WO2017101583A1 PCT/CN2016/102624 CN2016102624W WO2017101583A1 WO 2017101583 A1 WO2017101583 A1 WO 2017101583A1 CN 2016102624 W CN2016102624 W CN 2016102624W WO 2017101583 A1 WO2017101583 A1 WO 2017101583A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
layer
core
film
skeleton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2016/102624
Other languages
French (fr)
Chinese (zh)
Inventor
李雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2017101583A1 publication Critical patent/WO2017101583A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials

Definitions

  • the invention relates to the field of interventional therapeutic medical devices, in particular to a method for preparing a covered blood vessel stent.
  • Interventional treatment of vascular stents is widely used in the treatment of cardiovascular and cerebrovascular diseases such as vascular occlusion.
  • vascular stents For example, it is often necessary to implant a stent graft, a metal stent of other small blood vessels, and the like in a large blood vessel such as an aorta.
  • the stent graft not only retains the support function of the common stent, but also effectively improves the abnormal hemodynamics of the diseased vessel.
  • the coated stent is generally coated with a PTFE resin, and the polytetrafluoroethylene resin is melted by high temperature, and then the film is bonded to the stent substrate under pressure. Under the action of heat, the middle of the film is easy to form suspension, which causes the film to be uneven, and the whole process consumes a large amount of energy, which makes the existing film-covered stent costly.
  • the object of the present invention is to provide a method for preparing a covered vascular stent, which overcomes the defect that the conventional polytetrafluoroethylene resin coating is subjected to high temperature treatment to cause uneven film formation.
  • the present invention provides a method for preparing a covered vascular stent, which comprises: (1) designing a processing core according to a vascular structure of a vascular stent to be implanted; and (2) processing the core.
  • the first layer of the stent is coated; (3) the stent skeleton is placed on the core on which the first layer of the stent is processed; and (4) the sleeve is coated and the first layer of the stent is processed.
  • the weight ratio of the polyvinylidene fluoride resin to the organic solvent in the polyvinylidene fluoride resin solution is 1: (4-100).
  • the polyvinylidene fluoride resin has a melt mass flow rate of from 1 to 20 g/10 min.
  • the organic solvent is at least one of dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and methyl ethyl ketone.
  • the film forming treatment includes a casting film forming treatment, an electrospinning film forming treatment, a controlled deposition film forming treatment, and a spray coating film forming treatment.
  • the temperature of the film forming treatment by the spray coating is from 10 to 90 °C.
  • the scaffold skeleton is a metal scaffold skeleton and/or a polymer scaffold skeleton.
  • the metal in the metal stent skeleton comprises stainless steel and/or nickel titanium alloy.
  • the method further comprises, in step (4), removing the core such that the first layer of stent film forms a cavity.
  • the material obtained by processing the core comprises a saccharide material
  • the operation of removing the core comprises removing the core using a liquid capable of dissolving the core
  • the saccharide substance comprises a monosaccharide, At least one of a disaccharide and a water-soluble polysaccharide.
  • the present invention dissolves the polyvinylidene fluoride resin in a solvent such as dimethylformamide to obtain a coating film, and solves the problem that the conventional polytetrafluoroethylene resin material needs to be subjected to high temperature treatment when it is used as a coating material.
  • the operation is simple and cost-effective, and the obtained coated vascular stent has good mechanical properties and biological properties.
  • the invention provides a preparation method of a covered blood vessel stent, which comprises: (1) designing a processing core according to a blood vessel structure to be implanted into a blood vessel stent; and (2) processing a first layer stent covering on the core a film; (3) a stent skeleton is placed on the core on which the first layer of the stent is processed; and (4) a processing on the core in which the stent frame is formed and the first layer of the stent is processed.
  • the core in order to obtain a core that is compatible with the vascular structure in a precise and convenient manner, preferably, in step (1), the core is processed by a 3D printing technique.
  • the blood vessel structure with the implanted stent portion can be obtained by medical means such as angiography, such as CT angiography, and then the vascular structure can be constructed in the computer according to the vascular structure of the stent to be implanted.
  • the 3D model is then processed by a 3D printer.
  • the size of the core can be adjusted according to the doctor's requirements while ensuring that the outer surface structure of the core is adapted to the inner wall structure of the blood vessel.
  • the error precision is designed, and the processing methods for different error precision should fall within the protection scope of the present invention. That is, since the stent graft is manufactured on the basis of the outer surface of the core, the stent graft needs to be implanted on the inner wall of the blood vessel, and therefore, when processing the core, it is necessary to design the core according to the doctor's request.
  • the outer surface dimension is less than the size of the inner wall of the blood vessel with the required error so that the final stent graft accommodates the inner wall of the blood vessel.
  • the core may be a hollow structure or a solid structure, and the invention is not limited thereto. Among them, the core is preferably a solid structure in consideration of convenient processing.
  • the first layer of the stent film is first processed on the core, and then the stent skeleton is placed on the core on which the first layer of the stent is processed, and then the second is processed on the stent skeleton.
  • the layer carrier is coated and the second layer of the stent is bonded to the first layer of the stent to achieve a combination of the coating material and the stent skeleton. That is, it will be supported by two layers of film before and after The frame skeleton is firmly sandwiched to achieve a stable combination of the two.
  • the stent coating is obtained by a film forming treatment using a polyvinylidene fluoride resin solution.
  • the weight ratio of the polyvinylidene fluoride resin to the organic solvent in the polyvinylidene fluoride resin solution can function to dissolve the polyvinylidene fluoride resin in a wide range, for example, the polyvinylidene fluoride resin and the organic solvent.
  • the weight ratio can be 1: (4-100).
  • the polyvinylidene fluoride resin mainly refers to a vinylidene fluoride homopolymer or a copolymer of vinylidene fluoride and other small amount of fluorine-containing vinyl monomer.
  • MFR melt mass flow rate
  • the melt flow rate of the polyvinylidene fluoride resin of the present invention may be from 1 to 20 g/10 min.
  • the solubility of the polyvinylidene fluoride resin in the solvent varies depending on the polymerization process and formulation of the polyvinylidene fluoride resin.
  • Conventional solvents are acetone, tetrahydrofuran, methyl ethyl ketone, dimethylformamide, dimethylacetamide, tetramethylurea, dimethyl sulfoxide, trimethyl phosphate, N-methylpyrrolidone, butyrolactone, and isophora.
  • the solvent is preferably at least one of dimethylformamide, dimethylacetamide, dimethyl sulfoxide and methyl ethyl ketone.
  • the film forming treatment may employ a polymer film forming treatment method commonly used in the art, such as a casting method, an electrospinning method, a controlled deposition method, or a spray coating method.
  • the casting method refers to a method in which a polymer solution is uniformly cast on a dry, smooth, and clean substrate, and then dried to form a film in a constant temperature oven.
  • the electrospinning method is to generate a charged jet by overcoming the surface tension under a high-voltage electrostatic field, and the jet stream is refined and split, and the finally solid polymer fiber falls on the substrate to form a fiber membrane.
  • the controlled deposition method refers to a method of depositing a film-forming material on a carrier to control conditions to form a film.
  • Spraying method refers to a method of atomizing a solution by using a high pressure air by using a pneumatic spray gun, and the droplets are pushed by the load gas to reach the substrate for deposition and drying to form a film; when the film forming process of the present invention is carried out by spraying, the film is lower.
  • the film can be sprayed on the core to form a film at a temperature.
  • the temperature of the film forming process by the spraying method is 10-90 ° C.
  • the scaffold skeleton may be selected from conventional framework materials in the art, and may be, for example, a metal scaffold skeleton and/or a polymer scaffold skeleton.
  • the metal in the metal stent skeleton may include stainless steel and/or nickel titanium alloy.
  • the bracket frame may be a single-ring ring member, and the bracket ring of different specifications is selected according to the specification of the core to be combined with the film after being applied to the core.
  • the stent skeleton may also be a whole wire to be wrapped on the outer surface of the core by wrapping and wrapping, thereby obtaining a suitable stent skeleton.
  • the method further comprises, in step (4), removing the core such that the first layer of stent film forms a cavity.
  • the core is designed and formed according to the structure of the human blood vessel to be implanted into the stent. After the stent graft is processed on the core, the core and the stent graft are separated, thereby obtaining a covered vessel stent having a cavity structure.
  • a core can be processed with a dissolvable material, for example, a core processed with a water-soluble material. More specifically, the core can be processed using a saccharide material, so that a solid core can be conveniently obtained.
  • the saccharide substance may include at least one of a monosaccharide, a disaccharide, and a water-soluble polysaccharide; further preferably, the saccharide may be maltose, sucrose, and fructose, and the maltose, sucrose, and fructose are The mass ratio can be 1: (1-5): (1-5).
  • the core may be removed using a liquid capable of dissolving the core to separate the core from the stent graft.
  • the core may also be made of a meltable material, as long as the core is melted by a heating device when the core is separated, and such deformation is also within the scope of the present invention.
  • vascular structure of the stent portion to be implanted by CT angiography, and then according to the stent to be implanted
  • the vascular structure of the site is constructed in a computer to form a three-dimensional model that fits the vascular structure, and then the core is processed by a 3D printer.
  • the core is mixed with maltose, sucrose and fructose at a mass ratio of 1:1:1.
  • the polyvinylidene fluoride resin FR901 (purchased from Shanghai San Aifu, melt mass flow rate 16g/10min) and dimethylformamide were mixed at a weight ratio of 1:10, stirred for 4 hours, and then defoamed to obtain a polyethylene bias. Fluoroethylene resin solution.
  • the obtained polyvinylidene fluoride resin solution is sprayed on the surface of the core to form a continuous first layer of the stent film.
  • the stainless steel stent frame is placed on the core coated with the first layer of the stent film, and then the polyvinylidene fluoride resin solution is sprayed again along the surface of the stainless steel stent frame under the same working conditions to form a discontinuity by using a pneumatic spray gun.
  • the second layer of the stent is coated, and the second layer of the stent is combined with the first layer of the stent to form a stent film having a thickness of 0.1 mm, and the stainless steel stent skeleton is coated therein.
  • the core was dissolved with water to obtain a covered vascular stent prepared by the present invention.
  • the obtained stent graft was implanted into the aorta of experimental animals (rabbit), and arterial angiography was performed after 4 weeks, 12 weeks, and 24 weeks.
  • the vascular patency of the stent graft was observed, the stent adherence performance, and the presence or absence of migration. Bit and so on.
  • the vascular structure of the part to be implanted is obtained by CT angiography, and then a three-dimensional model of the vascular structure is constructed in the computer according to the vascular structure of the part to be implanted, and then the core is processed and manufactured by a 3D printer. Using maltose, sucrose and glucose by mass ratio Mix for 1:2:5.
  • the polyvinylidene fluoride resin FR921 (purchased from Shanghai San Aifu, melt mass flow rate 2g/10min) and dimethylacetamide were mixed at a weight ratio of 1:80, stirred for 4 hours, and then defoamed to obtain a polyethylene bias. Fluoroethylene resin solution.
  • the obtained polyvinylidene fluoride resin solution is cast into a mold in which a core is placed, and the polyvinylidene fluoride resin solution is cast on the surface of the core to form a continuous first layer of the stent film.
  • the nickel-titanium alloy support skeleton is set on the core which is cast into the film with the first layer of the stent film, and then placed in the mold again, and the polyvinylidene fluoride resin solution is cast again to form the second layer of the stent film.
  • the two-layer stent film is combined with the first layer of the stent film to form a stent film having a thickness of 0.2 mm, and the nickel-titanium alloy stent skeleton is coated therein.
  • the core was dissolved with water to obtain a covered vascular stent prepared by the present invention.
  • the obtained stent graft was implanted into the aorta of experimental animals (rabbit), and arterial angiography was performed after 4 weeks, 12 weeks, and 24 weeks.
  • the vascular patency of the stent graft was observed, the stent adherence performance, and the presence or absence of migration. Bit and so on.

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Disclosed is a method for preparing a membrane-covered intravascular stent. The method comprises: (1) designing a processing mold core according to a blood vessel structure needing an intravascular stent to be implanted; (2) processing a first layer stent membrane covering on the mold core; (3) sheathing a stent skeleton on the mold core processed with the first layer stent membrane covering; (4) processing a second layer membrane covering on the mold core which is sheathed with the stent skeleton and processed with the first layer stent membrane covering so that the second layer stent membrane covering is bonded to the first layer stent membrane covering and thus the stent skeleton is at least partly coated in the membrane covering, wherein when the first layer stent membrane covering and/or the second layer stent membrane covering are processed, a polyvinylidene fluoride resin solution is used for a membrane forming process. The preparation method can obtain the stent membrane covering through simple operations and saves on cost. The obtained membrane-covered intravascular stent has good mechanical properties and biological properties.

Description

覆膜血管支架的制备方法Preparation method of covered vascular stent 技术领域Technical field

本发明涉及介入治疗医疗器械领域,具体地,涉及一种覆膜血管支架的制备方法。The invention relates to the field of interventional therapeutic medical devices, in particular to a method for preparing a covered blood vessel stent.

背景技术Background technique

血管支架的介入治疗在血管阻塞等心脑血管疾病的治疗中应用广泛。例如在主动脉等大血管中经常需要植入覆膜支架,以及其他小血管的金属支架等等。覆膜支架既保留了普通支架的支撑功能,又能有效地改善病变血管的异常血流动力学。目前的覆膜支架一般采用聚四氟乙烯树脂对支撑材料进行包覆,需利用高温将聚四氟乙烯树脂熔融,然后在压力作用下使薄膜与支架基体发生粘合。热作用下,覆膜中间易形成悬浮,造成覆膜不均匀,且整个过程耗能较大,使得现有的覆膜支架成本较高。Interventional treatment of vascular stents is widely used in the treatment of cardiovascular and cerebrovascular diseases such as vascular occlusion. For example, it is often necessary to implant a stent graft, a metal stent of other small blood vessels, and the like in a large blood vessel such as an aorta. The stent graft not only retains the support function of the common stent, but also effectively improves the abnormal hemodynamics of the diseased vessel. At present, the coated stent is generally coated with a PTFE resin, and the polytetrafluoroethylene resin is melted by high temperature, and then the film is bonded to the stent substrate under pressure. Under the action of heat, the middle of the film is easy to form suspension, which causes the film to be uneven, and the whole process consumes a large amount of energy, which makes the existing film-covered stent costly.

发明内容Summary of the invention

本发明的目的是提供一种覆膜血管支架的制备方法,以克服传统聚四氟乙烯树脂覆膜需经高温处理造成成膜不均匀的缺陷。The object of the present invention is to provide a method for preparing a covered vascular stent, which overcomes the defect that the conventional polytetrafluoroethylene resin coating is subjected to high temperature treatment to cause uneven film formation.

为了实现上述目的,本发明提供一种覆膜血管支架的制备方法,该制备方法包括:(1)根据待植入血管支架的血管结构设计加工型芯;(2)在所述型芯上加工第一层支架覆膜;(3)将支架骨架套装在加工有第一层支架覆膜的所述型芯上;(4)在套装有支架骨架且加工有第一层支架覆膜的所述型芯上加工第二层覆膜,并使得该第二层支架覆膜与所述第一层支架覆膜结合,以使得所述支架骨架至少部分包覆在覆膜中;其中,加工所述第一层支架覆膜时和/或加工所述第二层支架覆膜时,使用聚偏氟乙烯树脂溶液进行成膜处 理。In order to achieve the above object, the present invention provides a method for preparing a covered vascular stent, which comprises: (1) designing a processing core according to a vascular structure of a vascular stent to be implanted; and (2) processing the core. The first layer of the stent is coated; (3) the stent skeleton is placed on the core on which the first layer of the stent is processed; and (4) the sleeve is coated and the first layer of the stent is processed. Processing a second layer of the film on the core, and bonding the second layer of the stent film to the first layer of the stent film such that the stent frame is at least partially coated in the film; wherein When the first layer of the stent is coated and/or when the second layer of the stent is coated, the film is formed using a polyvinylidene fluoride resin solution. Reason.

优选地,所述聚偏氟乙烯树脂溶液中聚偏氟乙烯树脂与有机溶剂的重量比为1:(4-100)。Preferably, the weight ratio of the polyvinylidene fluoride resin to the organic solvent in the polyvinylidene fluoride resin solution is 1: (4-100).

优选地,所述聚偏氟乙烯树脂的熔体质量流动速率为1-20g/10min。Preferably, the polyvinylidene fluoride resin has a melt mass flow rate of from 1 to 20 g/10 min.

优选地,所述有机溶剂为二甲基甲酰胺、二甲基乙酰胺、二甲基亚砜和甲乙酮中的至少一种。Preferably, the organic solvent is at least one of dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and methyl ethyl ketone.

优选地,所述成膜处理包括流延法成膜处理、电纺丝法成膜处理、可控沉积法成膜处理和喷涂法成膜处理。Preferably, the film forming treatment includes a casting film forming treatment, an electrospinning film forming treatment, a controlled deposition film forming treatment, and a spray coating film forming treatment.

优选地,所述喷涂法成膜处理的温度为10-90℃。Preferably, the temperature of the film forming treatment by the spray coating is from 10 to 90 °C.

优选地,所述支架骨架为金属支架骨架和/或高分子支架骨架。Preferably, the scaffold skeleton is a metal scaffold skeleton and/or a polymer scaffold skeleton.

优选地,所述金属支架骨架中的金属包括不锈钢和/或镍钛合金。Preferably, the metal in the metal stent skeleton comprises stainless steel and/or nickel titanium alloy.

优选地,该方法还包括:在步骤(4)中,去除所述型芯以使得所述第一层支架覆膜形成腔体。Preferably, the method further comprises, in step (4), removing the core such that the first layer of stent film forms a cavity.

优选地,加工得到所述型芯的材料包括糖类物质,去除所述型芯的操作包括使用能够溶解所述型芯的液体对所述型芯进行去除;所述糖类物质包括单糖、双糖和水溶性多糖中的至少一种。Preferably, the material obtained by processing the core comprises a saccharide material, and the operation of removing the core comprises removing the core using a liquid capable of dissolving the core; the saccharide substance comprises a monosaccharide, At least one of a disaccharide and a water-soluble polysaccharide.

通过上述技术方案,本发明将聚偏氟乙烯树脂溶于二甲基甲酰胺等溶剂中即可得到覆膜,解决了传统聚四氟乙烯树脂材料做覆膜材料时需经高温处理的问题,操作简单,节约成本,所得覆膜血管支架具有良好的力学性能和生物性能。According to the above technical solution, the present invention dissolves the polyvinylidene fluoride resin in a solvent such as dimethylformamide to obtain a coating film, and solves the problem that the conventional polytetrafluoroethylene resin material needs to be subjected to high temperature treatment when it is used as a coating material. The operation is simple and cost-effective, and the obtained coated vascular stent has good mechanical properties and biological properties.

本发明的其他特征和优点将在随后的具体实施方式部分予以详细说明。Other features and advantages of the invention will be described in detail in the detailed description which follows.

具体实施方式detailed description

以下对本发明的具体实施方式进行详细说明。应当理解的是,此处所描述的具体实施方式仅用于说明和解释本发明,并不用于限制本发明。 Specific embodiments of the present invention will be described in detail below. It is to be understood that the specific embodiments described herein are merely illustrative and not restrictive.

本发明提供一种覆膜血管支架的制备方法,该制备方法包括:(1)根据待植入血管支架的血管结构设计加工型芯;(2)在所述型芯上加工第一层支架覆膜;(3)将支架骨架套装在加工有第一层支架覆膜的所述型芯上;(4)在套装有支架骨架且加工有第一层支架覆膜的所述型芯上加工第二层覆膜,并使得该第二层支架覆膜与所述第一层支架覆膜结合,以使得所述支架骨架至少部分包覆在覆膜中;其中,加工所述第一层支架覆膜时和/或加工所述第二层支架覆膜时,使用聚偏氟乙烯树脂溶液进行成膜处理。The invention provides a preparation method of a covered blood vessel stent, which comprises: (1) designing a processing core according to a blood vessel structure to be implanted into a blood vessel stent; and (2) processing a first layer stent covering on the core a film; (3) a stent skeleton is placed on the core on which the first layer of the stent is processed; and (4) a processing on the core in which the stent frame is formed and the first layer of the stent is processed. Laminating the second layer and bonding the second layer of the stent to the first layer of the stent so that the stent is at least partially coated in the coating; wherein the first stent is processed When the film is coated and/or the second layer of the stent is processed, a film formation treatment is performed using a polyvinylidene fluoride resin solution.

在本发明的优选实施方式中,为了精确方便地得到与血管结构切合的型芯,优选地,在步骤(1)中,通过3D打印技术加工型芯。具体地,在设计型芯时,可以通过造影等医学手段得到带植入支架部分的血管结构,例如CT造影,然后根据该待植入支架部位的血管结构在计算机中构建与该血管结构切合的三维模型,然后通过3D打印机完成型芯的加工制造。其中需要注意的是,由于最终得到的血管支架需要与血管内壁相适应,因此在保证该型芯的外表面结构与血管的内壁结构相适应的同时,型芯的尺寸规格可以根据医生所需的误差精度来设计,对于不同误差精度的加工方法均应落在本发明的保护范围内。即,由于覆膜支架是以型芯的外表面为基准而制造的,覆膜支架需要植入到血管的内壁上,因此还需在加工型芯时,需要根据医生的要求,设计使得型芯外表面尺寸以所需误差小于血管内壁的尺寸,以使得最终的覆膜支架适应血管内壁。其中,型芯其可以为空心结构也可以为实心结构,对此本发明不做限制。其中考虑到方便加工,型芯优选为实心结构体。In a preferred embodiment of the invention, in order to obtain a core that is compatible with the vascular structure in a precise and convenient manner, preferably, in step (1), the core is processed by a 3D printing technique. Specifically, when designing the core, the blood vessel structure with the implanted stent portion can be obtained by medical means such as angiography, such as CT angiography, and then the vascular structure can be constructed in the computer according to the vascular structure of the stent to be implanted. The 3D model is then processed by a 3D printer. It should be noted that, since the finally obtained vascular stent needs to be adapted to the inner wall of the blood vessel, the size of the core can be adjusted according to the doctor's requirements while ensuring that the outer surface structure of the core is adapted to the inner wall structure of the blood vessel. The error precision is designed, and the processing methods for different error precision should fall within the protection scope of the present invention. That is, since the stent graft is manufactured on the basis of the outer surface of the core, the stent graft needs to be implanted on the inner wall of the blood vessel, and therefore, when processing the core, it is necessary to design the core according to the doctor's request. The outer surface dimension is less than the size of the inner wall of the blood vessel with the required error so that the final stent graft accommodates the inner wall of the blood vessel. Wherein, the core may be a hollow structure or a solid structure, and the invention is not limited thereto. Among them, the core is preferably a solid structure in consideration of convenient processing.

为了完成覆膜血管支架的加工,需要在型芯上将支架骨架和支架覆膜相互结合。为了便于将二者相结合,首先在型芯上加工第一层支架覆膜,然后将支架骨架套装在加工有第一层支架覆膜的所述型芯上,再在支架骨架上加工第二层支架覆膜,并使得该第二层支架覆膜与所述第一层支架覆膜结合,以实现所述覆膜材料和所述支架骨架的结合。即,通过前后的两层覆膜将支 架骨架牢固夹在之中,以实现二者稳定的结合。In order to complete the processing of the covered vascular stent, it is necessary to combine the stent skeleton and the stent coating on the core. In order to facilitate the combination of the two, the first layer of the stent film is first processed on the core, and then the stent skeleton is placed on the core on which the first layer of the stent is processed, and then the second is processed on the stent skeleton. The layer carrier is coated and the second layer of the stent is bonded to the first layer of the stent to achieve a combination of the coating material and the stent skeleton. That is, it will be supported by two layers of film before and after The frame skeleton is firmly sandwiched to achieve a stable combination of the two.

根据本发明,所述支架覆膜为使用聚偏氟乙烯树脂溶液进行成膜处理所得。所述聚偏氟乙烯树脂溶液中聚偏氟乙烯树脂与有机溶剂的重量比在较宽范围内都可以起到使聚偏氟乙烯树脂溶解的作用,例如所述聚偏氟乙烯树脂与有机溶剂的重量比可以为1:(4-100)。According to the invention, the stent coating is obtained by a film forming treatment using a polyvinylidene fluoride resin solution. The weight ratio of the polyvinylidene fluoride resin to the organic solvent in the polyvinylidene fluoride resin solution can function to dissolve the polyvinylidene fluoride resin in a wide range, for example, the polyvinylidene fluoride resin and the organic solvent. The weight ratio can be 1: (4-100).

根据本发明,所述聚偏氟乙烯树脂(PVDF)主要是指偏氟乙烯均聚物或者偏氟乙烯与其他少量含氟乙烯基单体的共聚物。对同一类高聚物可通过熔体质量流动速率(MFR)比较分子量的大小,聚合度越大即分子量越大则熔体质量流动速率越小,反之分子量小则熔体流动速率大。本发明所述聚偏氟乙烯树脂的熔体质量流动速率可以为1-20g/10min。According to the present invention, the polyvinylidene fluoride resin (PVDF) mainly refers to a vinylidene fluoride homopolymer or a copolymer of vinylidene fluoride and other small amount of fluorine-containing vinyl monomer. For the same kind of high polymer, the molecular weight can be compared by the melt mass flow rate (MFR). The larger the degree of polymerization, that is, the larger the molecular weight, the smaller the melt mass flow rate, and the smaller the molecular weight, the larger the melt flow rate. The melt flow rate of the polyvinylidene fluoride resin of the present invention may be from 1 to 20 g/10 min.

聚偏氟乙烯树脂在溶剂中的溶解性随着聚偏氟乙烯树脂的聚合工艺及配方的不同而变化。常规的溶剂有丙酮、四氢呋喃、甲乙酮、二甲基甲酰胺、二甲基乙酰胺、四甲基脲、二甲基亚砜、磷酸三甲酯、N-甲基吡咯烷酮、丁内酯、异佛尔酮、醋酸卡必醇酯、甲基异丁基酮、醋酸丁酯、环己酮、二异丁基酮、乙酰醋酸乙酯和磷酸三乙酯等。根据本发明,所述溶剂优选为二甲基甲酰胺、二甲基乙酰胺、二甲基亚砜和甲乙酮中的至少一种。The solubility of the polyvinylidene fluoride resin in the solvent varies depending on the polymerization process and formulation of the polyvinylidene fluoride resin. Conventional solvents are acetone, tetrahydrofuran, methyl ethyl ketone, dimethylformamide, dimethylacetamide, tetramethylurea, dimethyl sulfoxide, trimethyl phosphate, N-methylpyrrolidone, butyrolactone, and isophora. Ketone, carbitol acetate, methyl isobutyl ketone, butyl acetate, cyclohexanone, diisobutyl ketone, ethyl acetoacetate and triethyl phosphate. According to the invention, the solvent is preferably at least one of dimethylformamide, dimethylacetamide, dimethyl sulfoxide and methyl ethyl ketone.

根据本发明,所述成膜处理可以采用本领域常用的聚合物成膜处理方法,例如流延法、电纺丝法、可控沉积法或喷涂法等。流延法是指将聚合物溶液在干燥、光滑且洁净的基体上均匀流延,然后在恒温烘箱中干燥成膜的方法。电纺丝法是将聚合物溶液在高压静电场下克服表面张力而产生带电喷射流,喷射流细化、分裂,最终固化的高聚物纤维落在基体上形成纤维膜。可控沉积法是指将成膜材料沉积在载体上,控制条件形成薄膜的方法。喷涂法是指采用气压喷枪,利用高压空气将溶液雾化,雾滴在载荷气体推动下到达基体沉积并干燥成膜的方法;采用喷涂法进行本发明所述的成膜处理时,在较低温度下即可在型芯上喷涂形成覆膜,优选地,所述喷涂法成膜处理的温度为 10-90℃。According to the present invention, the film forming treatment may employ a polymer film forming treatment method commonly used in the art, such as a casting method, an electrospinning method, a controlled deposition method, or a spray coating method. The casting method refers to a method in which a polymer solution is uniformly cast on a dry, smooth, and clean substrate, and then dried to form a film in a constant temperature oven. The electrospinning method is to generate a charged jet by overcoming the surface tension under a high-voltage electrostatic field, and the jet stream is refined and split, and the finally solid polymer fiber falls on the substrate to form a fiber membrane. The controlled deposition method refers to a method of depositing a film-forming material on a carrier to control conditions to form a film. Spraying method refers to a method of atomizing a solution by using a high pressure air by using a pneumatic spray gun, and the droplets are pushed by the load gas to reach the substrate for deposition and drying to form a film; when the film forming process of the present invention is carried out by spraying, the film is lower. The film can be sprayed on the core to form a film at a temperature. Preferably, the temperature of the film forming process by the spraying method is 10-90 ° C.

根据本发明,所述支架骨架可以选自本领域常规骨架材料,例如可以为为金属支架骨架和/或高分子支架骨架。所述金属支架骨架中的金属可以包括不锈钢和/或镍钛合金。所述支架骨架可以为单圈的环件,根据型芯的规格选用不同规格的支架环以备与在套装到型芯上后与覆膜相结合。此外,支架骨架也可以为整条丝线,以通过缠绕包覆的方式套装到型芯的外表面上,从而得到适宜的支架骨架。According to the present invention, the scaffold skeleton may be selected from conventional framework materials in the art, and may be, for example, a metal scaffold skeleton and/or a polymer scaffold skeleton. The metal in the metal stent skeleton may include stainless steel and/or nickel titanium alloy. The bracket frame may be a single-ring ring member, and the bracket ring of different specifications is selected according to the specification of the core to be combined with the film after being applied to the core. In addition, the stent skeleton may also be a whole wire to be wrapped on the outer surface of the core by wrapping and wrapping, thereby obtaining a suitable stent skeleton.

根据本发明,该方法还包括:在步骤(4)中,去除所述型芯以使得所述第一层支架覆膜形成腔体。所述型芯根据待植入支架的人体血管结构设计加工形成,在该型芯上加工覆膜支架后需将该型芯与覆膜支架分离,从而得到具有空腔结构的覆膜血管支架。According to the invention, the method further comprises, in step (4), removing the core such that the first layer of stent film forms a cavity. The core is designed and formed according to the structure of the human blood vessel to be implanted into the stent. After the stent graft is processed on the core, the core and the stent graft are separated, thereby obtaining a covered vessel stent having a cavity structure.

其中为了便于型芯的加工,可以采用可溶解材料加工型芯,例如采用水溶性材料加工型芯。更具体地,可以使用糖类物质加工型芯,这样可以方便地得到固态的型芯。优选地,所述糖类物质可以包括单糖、双糖和水溶性多糖中的至少一种;进一步优选地,所述糖类物质可以为麦芽糖、蔗糖和果糖,所述麦芽糖、蔗糖和果糖是质量比可以为1:(1-5):(1-5)。另外重要地,使用液溶性材料加工型芯是为了更好地实现型芯和制造完毕的覆膜支架相互分离。其中优选地,为了快捷地将型芯与覆膜支架分离,可以使用能够溶解所述型芯的液体对所述型芯进行去除,以使得型芯与覆膜支架分离。在其他实施方式中,型芯还可以采用可熔化材料制成,只要在分离型芯时,采用加热设备将型芯熔化即可,对于此种变形方式也应落在本发明的保护范围中。In order to facilitate the processing of the core, a core can be processed with a dissolvable material, for example, a core processed with a water-soluble material. More specifically, the core can be processed using a saccharide material, so that a solid core can be conveniently obtained. Preferably, the saccharide substance may include at least one of a monosaccharide, a disaccharide, and a water-soluble polysaccharide; further preferably, the saccharide may be maltose, sucrose, and fructose, and the maltose, sucrose, and fructose are The mass ratio can be 1: (1-5): (1-5). In addition, it is important to use a liquid-soluble material to process the core in order to better achieve the separation of the core and the manufactured stent. Preferably, in order to quickly separate the core from the stent graft, the core may be removed using a liquid capable of dissolving the core to separate the core from the stent graft. In other embodiments, the core may also be made of a meltable material, as long as the core is melted by a heating device when the core is separated, and such deformation is also within the scope of the present invention.

以下通过实施例进一步进行说明,但并不因此而限制本发明。The following examples are further described, but the invention is not limited thereby.

实施例1Example 1

通过CT造影得到待植入支架部分的血管结构,然后根据该待植入支架 部位的血管结构在计算机中构建与该血管结构切合的三维模型,然后通过3D打印机完成型芯的加工制造,型芯采用麦芽糖、蔗糖和果糖按质量比为1:1:1进行混合。Obtaining the vascular structure of the stent portion to be implanted by CT angiography, and then according to the stent to be implanted The vascular structure of the site is constructed in a computer to form a three-dimensional model that fits the vascular structure, and then the core is processed by a 3D printer. The core is mixed with maltose, sucrose and fructose at a mass ratio of 1:1:1.

将聚偏氟乙烯树脂FR901(购自上海三爱富,熔体质量流动速率16g/10min)与二甲基甲酰胺按重量比为1:10混合,搅拌4h后静置消泡,得到聚偏氟乙烯树脂溶液。The polyvinylidene fluoride resin FR901 (purchased from Shanghai San Aifu, melt mass flow rate 16g/10min) and dimethylformamide were mixed at a weight ratio of 1:10, stirred for 4 hours, and then defoamed to obtain a polyethylene bias. Fluoroethylene resin solution.

采用气压喷枪在0.3MPa气压、30℃温度下,喷嘴与型芯表面距离150mm时,将所得聚偏氟乙烯树脂溶液喷涂于型芯表面形成连续的第一层支架覆膜。When the distance between the nozzle and the core surface is 150 mm at a pressure of 0.3 MPa and 30 ° C using a pneumatic spray gun, the obtained polyvinylidene fluoride resin solution is sprayed on the surface of the core to form a continuous first layer of the stent film.

将不锈钢支架骨架套装在喷涂有第一层支架覆膜的型芯上,然后用气压喷枪,在同样的上述工作条件下将聚偏氟乙烯树脂溶液沿着不锈钢支架骨架的表面再次喷涂形成不连续的第二层支架覆膜,第二层支架覆膜与第一层支架覆膜结合,形成厚度为0.1mm的支架覆膜,并将不锈钢支架骨架包覆于其中。The stainless steel stent frame is placed on the core coated with the first layer of the stent film, and then the polyvinylidene fluoride resin solution is sprayed again along the surface of the stainless steel stent frame under the same working conditions to form a discontinuity by using a pneumatic spray gun. The second layer of the stent is coated, and the second layer of the stent is combined with the first layer of the stent to form a stent film having a thickness of 0.1 mm, and the stainless steel stent skeleton is coated therein.

用水将型芯溶解,得到本发明所制备的覆膜血管支架。The core was dissolved with water to obtain a covered vascular stent prepared by the present invention.

将所得覆膜支架植入实验动物(兔)的主动脉内,4周、12周、24周后进行动脉血管造影检查,观察覆膜支架植入血管通畅情况、支架贴壁性能、有无移位等。The obtained stent graft was implanted into the aorta of experimental animals (rabbit), and arterial angiography was performed after 4 weeks, 12 weeks, and 24 weeks. The vascular patency of the stent graft was observed, the stent adherence performance, and the presence or absence of migration. Bit and so on.

动物植入实验表明,所有实验动物(兔)在随访期存活良好,支架植入部位血管保持通畅,无血栓形成。覆膜无皱缩、破裂等现象,无并发症、血液渗漏、支架移位,覆膜支架贴壁较好且具备良好的生物相容性。Animal implantation experiments showed that all experimental animals (rabbits) survived well during the follow-up period, and the vessels at the site of stent implantation remained unobstructed without thrombosis. There is no shrinkage, rupture, etc. of the film, no complications, blood leakage, stent displacement, and the stent graft is well attached and has good biocompatibility.

实施例2Example 2

通过CT造影得到待植入支架部分的血管结构,然后根据该待植入支架部位的血管结构在计算机中构建与该血管结构切合的三维模型,然后通过3D打印机完成型芯的加工制造,型芯采用麦芽糖、蔗糖和葡萄糖按质量比 为1:2:5进行混合。The vascular structure of the part to be implanted is obtained by CT angiography, and then a three-dimensional model of the vascular structure is constructed in the computer according to the vascular structure of the part to be implanted, and then the core is processed and manufactured by a 3D printer. Using maltose, sucrose and glucose by mass ratio Mix for 1:2:5.

将聚偏氟乙烯树脂FR921(购自上海三爱富,熔体质量流动速率2g/10min)与二甲基乙酰胺按重量比为1:80混合,搅拌4h后静置消泡,得到聚偏氟乙烯树脂溶液。The polyvinylidene fluoride resin FR921 (purchased from Shanghai San Aifu, melt mass flow rate 2g/10min) and dimethylacetamide were mixed at a weight ratio of 1:80, stirred for 4 hours, and then defoamed to obtain a polyethylene bias. Fluoroethylene resin solution.

将所得聚偏氟乙烯树脂溶液浇注至放有型芯的模具内,使聚偏氟乙烯树脂溶液流延于型芯表面形成连续的第一层支架覆膜。The obtained polyvinylidene fluoride resin solution is cast into a mold in which a core is placed, and the polyvinylidene fluoride resin solution is cast on the surface of the core to form a continuous first layer of the stent film.

将镍钛合金支架骨架套装在流延成膜有第一层支架覆膜的型芯上,然后再次放入模具内,使聚偏氟乙烯树脂溶液再次流延形成第二层支架覆膜,第二层支架覆膜与第一层支架覆膜结合,形成厚度为0.2mm的支架覆膜,并将镍钛合金支架骨架包覆于其中。The nickel-titanium alloy support skeleton is set on the core which is cast into the film with the first layer of the stent film, and then placed in the mold again, and the polyvinylidene fluoride resin solution is cast again to form the second layer of the stent film. The two-layer stent film is combined with the first layer of the stent film to form a stent film having a thickness of 0.2 mm, and the nickel-titanium alloy stent skeleton is coated therein.

用水将型芯溶解,得到本发明所制备的覆膜血管支架。The core was dissolved with water to obtain a covered vascular stent prepared by the present invention.

将所得覆膜支架植入实验动物(兔)的主动脉内,4周、12周、24周后进行动脉血管造影检查,观察覆膜支架植入血管通畅情况、支架贴壁性能、有无移位等。The obtained stent graft was implanted into the aorta of experimental animals (rabbit), and arterial angiography was performed after 4 weeks, 12 weeks, and 24 weeks. The vascular patency of the stent graft was observed, the stent adherence performance, and the presence or absence of migration. Bit and so on.

动物植入实验表明,所有实验动物(兔)在随访期存活良好,支架植入部位血管保持通畅,无血栓形成。覆膜无皱缩、破裂等现象,无并发症、血液渗漏、支架移位,覆膜支架贴壁较好且具备良好的生物相容性。 Animal implantation experiments showed that all experimental animals (rabbits) survived well during the follow-up period, and the vessels at the site of stent implantation remained unobstructed without thrombosis. There is no shrinkage, rupture, etc. of the film, no complications, blood leakage, stent displacement, and the stent graft is well attached and has good biocompatibility.

Claims (10)

一种覆膜血管支架的制备方法,其特征在于,该制备方法包括:A method for preparing a covered vascular stent, characterized in that the preparation method comprises: (1)根据待植入血管支架的血管结构设计加工型芯;(1) designing a processing core according to the vascular structure of the stent to be implanted; (2)在所述型芯上加工第一层支架覆膜;(2) processing the first layer of the stent film on the core; (3)将支架骨架套装在加工有第一层支架覆膜的所述型芯上;(3) arranging the scaffold skeleton on the core body processed with the first layer of the stent film; (4)在套装有支架骨架且加工有第一层支架覆膜的所述型芯上加工第二层覆膜,并使得该第二层支架覆膜与所述第一层支架覆膜结合,以使得所述支架骨架至少部分包覆在覆膜中;其中,加工所述第一层支架覆膜时和/或加工所述第二层支架覆膜时,使用聚偏氟乙烯树脂溶液进行成膜处理。(4) processing a second layer of the film on the core having the stent frame and processing the first layer of the stent film, and bonding the second layer of the stent film to the first layer of the stent film, So that the scaffold skeleton is at least partially coated in the coating film; wherein, when the first layer of the stent coating is processed and/or the second layer of the stent is processed, the polyvinylidene fluoride resin solution is used for forming Membrane treatment. 根据权利要求1所述的方法,其中,所述聚偏氟乙烯树脂溶液中聚偏氟乙烯树脂与有机溶剂的重量比为1:(4-100)。The method according to claim 1, wherein a weight ratio of the polyvinylidene fluoride resin to the organic solvent in the polyvinylidene fluoride resin solution is 1: (4-100). 根据权利要求1或2所述的方法,其中,所述聚偏氟乙烯树脂的熔体质量流动速率为1-20g/10min。The method according to claim 1 or 2, wherein the polyvinylidene fluoride resin has a melt mass flow rate of from 1 to 20 g/10 min. 根据权利要求2所述的方法,其中,所述有机溶剂为选自二甲基甲酰胺、二甲基乙酰胺、二甲基亚砜和甲乙酮中的至少一种。The method according to claim 2, wherein the organic solvent is at least one selected from the group consisting of dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and methyl ethyl ketone. 根据权利要求1所述的方法,其中,所述成膜处理包括流延法成膜处理、电纺丝法成膜处理、可控沉积法成膜处理和喷涂法成膜处理。The method according to claim 1, wherein the film forming treatment comprises a casting film forming treatment, an electrospinning film forming treatment, a controlled deposition film forming treatment, and a spray coating film forming treatment. 根据权利要求5所述的方法,其中,所述喷涂法成膜处理的温度为10-90℃。 The method according to claim 5, wherein the temperature of the film forming treatment by the spray coating is from 10 to 90 °C. 根据权利要求1所述的方法,其中,所述支架骨架为金属支架骨架和/或高分子支架骨架。The method of claim 1 wherein the scaffold skeleton is a metal scaffold skeleton and/or a polymeric scaffold skeleton. 根据权利要求7所述的方法,其中,所述金属支架骨架中的金属包括不锈钢和/或镍钛合金。The method of claim 7 wherein the metal in the metal stent skeleton comprises stainless steel and/or nickel titanium alloy. 根据权利要求1所述的方法,其中,该方法还包括:在步骤(4)中,去除所述型芯以使得所述第一层支架覆膜形成腔体。The method of claim 1 wherein the method further comprises, in step (4), removing the core such that the first layer of stent film forms a cavity. 根据权利要求9所述的方法,其中,加工得到所述型芯的材料包括糖类物质,去除所述型芯的操作包括使用能够溶解所述型芯的液体对所述型芯进行去除;所述糖类物质包括单糖、双糖和水溶性多糖中的至少一种。 The method of claim 9 wherein the material from which the core is processed comprises a saccharide material, and the removing the core comprises removing the core using a liquid capable of dissolving the core; The saccharide substance includes at least one of a monosaccharide, a disaccharide, and a water-soluble polysaccharide.
PCT/CN2016/102624 2015-12-14 2016-10-19 Method for preparing membrane-covered intravascular stent Ceased WO2017101583A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510926357.7 2015-12-14
CN201510926357.7A CN105435314A (en) 2015-12-14 2015-12-14 Preparation method of covered endovascular stent-graft

Publications (1)

Publication Number Publication Date
WO2017101583A1 true WO2017101583A1 (en) 2017-06-22

Family

ID=55546229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/102624 Ceased WO2017101583A1 (en) 2015-12-14 2016-10-19 Method for preparing membrane-covered intravascular stent

Country Status (2)

Country Link
CN (1) CN105435314A (en)
WO (1) WO2017101583A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114041898A (en) * 2021-11-18 2022-02-15 武汉奥绿新生物科技股份有限公司 Covered stent and preparation method thereof
CN118065029A (en) * 2024-02-03 2024-05-24 武汉纺织大学 Polymer yarn braided ureteral stent with scale inhibition and preparation method thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106264781A (en) * 2015-06-25 2017-01-04 李雷 The manufacture method of overlay film frame, system
CN105435314A (en) * 2015-12-14 2016-03-30 李雷 Preparation method of covered endovascular stent-graft
CN106491241A (en) * 2016-11-21 2017-03-15 清华大学 A kind of forming method of aorta tectorial membrane stent
JP2022524524A (en) * 2019-03-11 2022-05-06 ゼルティス アーゲー Electrospun polymer assembly for medical implants
CN110115648B (en) * 2019-05-15 2021-01-22 四川兴泰普乐医疗科技有限公司 Preparation method of degradable intravascular stent by 3D printing
CN111419470B (en) * 2020-03-17 2022-08-30 首都医科大学附属北京安贞医院 Support laminating machine

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1654028A (en) * 2005-01-21 2005-08-17 清华大学 A method for forming complex tube-network scaffolds for tissue engineering based on dissolving core technology
CN1715312A (en) * 2004-07-02 2006-01-04 中国科学院上海应用物理研究所 A kind of preparation method of medical polymer superhydrophobic film
CN101627933A (en) * 2008-07-17 2010-01-20 微创医疗器械(上海)有限公司 Covered stent
CN101703812A (en) * 2009-11-20 2010-05-12 东华大学 Polyamide 66 membrane covered nickel-titanium alloy intravascular scaffold and preparation method thereof
US20100324667A1 (en) * 2004-06-22 2010-12-23 Boston Scientific Scimed, Inc. Implantable medical devices with anti-microbial and biodegradable matrices
CN105435314A (en) * 2015-12-14 2016-03-30 李雷 Preparation method of covered endovascular stent-graft

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300459B2 (en) * 2002-10-17 2007-11-27 Heuser Richard R Stent with covering and differential dilation
CN2822554Y (en) * 2005-07-27 2006-10-04 深圳市先健科技股份有限公司 Blood vessel covering film holder of non sewing line for prepenting shifting
CN101744671B (en) * 2008-12-16 2011-08-17 上海冠芯电子科技有限公司 Manufacturing method of cochlea electrode
CN203436435U (en) * 2013-07-01 2014-02-19 雅伦生物科技(北京)有限公司 Cerebrovascular drug-eluting stent
CN104383612A (en) * 2014-11-04 2015-03-04 胡堃 Vascular stent and preparation method thereof
CN105105894A (en) * 2015-07-20 2015-12-02 宁波琳盛高分子材料有限公司 Reinforced compound sheathing canal, preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100324667A1 (en) * 2004-06-22 2010-12-23 Boston Scientific Scimed, Inc. Implantable medical devices with anti-microbial and biodegradable matrices
CN1715312A (en) * 2004-07-02 2006-01-04 中国科学院上海应用物理研究所 A kind of preparation method of medical polymer superhydrophobic film
CN1654028A (en) * 2005-01-21 2005-08-17 清华大学 A method for forming complex tube-network scaffolds for tissue engineering based on dissolving core technology
CN101627933A (en) * 2008-07-17 2010-01-20 微创医疗器械(上海)有限公司 Covered stent
CN101703812A (en) * 2009-11-20 2010-05-12 东华大学 Polyamide 66 membrane covered nickel-titanium alloy intravascular scaffold and preparation method thereof
CN105435314A (en) * 2015-12-14 2016-03-30 李雷 Preparation method of covered endovascular stent-graft

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114041898A (en) * 2021-11-18 2022-02-15 武汉奥绿新生物科技股份有限公司 Covered stent and preparation method thereof
CN118065029A (en) * 2024-02-03 2024-05-24 武汉纺织大学 Polymer yarn braided ureteral stent with scale inhibition and preparation method thereof

Also Published As

Publication number Publication date
CN105435314A (en) 2016-03-30

Similar Documents

Publication Publication Date Title
WO2017101583A1 (en) Method for preparing membrane-covered intravascular stent
WO2017101582A1 (en) Covered endovascular stent-graft
US20120179237A1 (en) Spray system and method of making phase separated polymer membrane structures
CN100490762C (en) A method for forming complex tube-network scaffolds for tissue engineering based on dissolving core technology
CN104203150B (en) composite prosthetic device
CN101454086B (en) Polymer coatings containing drug powders in controlled morphology
CN100566764C (en) A drug-coated carrier for drug-coated vascular stent and preparation method of drug-coated vascular stent
US20050033414A1 (en) Drug-eluting stent with multi-layer coatings
JPWO1995003075A1 (en) Medical materials and their manufacturing methods
WO1995003075A1 (en) Medical material and process for producing the same
KR20170006909A (en) Bio tubular scaffold for fabricating artificial vascular and the fabricating method thereof
CN110575607B (en) Medicine saccule
US20080193497A1 (en) Hydrophilic Coating of a Water-Swellable Hydrophilic Matrix and an Anti-Microbial Polymer
CN102552992A (en) Multilayered composite tube, manufacturing method thereof, and application thereof
CN101951971A (en) Biologically active substance coating method and tube
US9833547B2 (en) Drug-coated balloon catheter and method for the production thereof
Perkins et al. Direct writing of bio‐functional coatings for cardiovascular applications
CN104353129A (en) Intravascular stent and preparation method thereof
JPH0567330B2 (en)
US20240082458A1 (en) Tubular material, preparation method therefor and use thereof
US20230293774A1 (en) Stent graft with elastomeric impermeable layer
WO2016206561A1 (en) Manufacturing method and system of covered stent
CN112317279A (en) Method for effectively improving easy separation of membrane and stent after hollow stent is covered with membrane
CN204170152U (en) A kind of intravascular stent
CN116173311A (en) A drug coating for expandable balloon catheter and its preparation method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16874641

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16874641

Country of ref document: EP

Kind code of ref document: A1